Literature DB >> 18772029

Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment.

Julián de Almeida1, José M Palacios, Guadalupe Mengod.   

Abstract

The prefrontal cortex (PFC) has attracted a great research interest because of its involvement in the control of executive functions in both health and disease, and particularly in cognitive functions such as working memory. In schizophrenia, alterations in the PFC are documented at many different levels: molecular, cellular and functional. Furthermore, deficits in cognitive abilities are considered a core feature of schizophrenia and remain a major unmet medical need with respect to this disorder. In order to understand the sites of action of currently used drugs, as well as of the new experimental treatments being developed and acting in this brain region, it is important to have a detailed knowledge of the corresponding chemical neuroanatomy. Here we review current knowledge regarding the cellular localization of 5-HT(1A), 5-HT(2A) and dopamine D1, D5, and D2, D4 receptors in primate PFC and their possible functions in the neuronal circuits of the PFC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772029     DOI: 10.1016/S0079-6123(08)00905-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  25 in total

1.  The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning.

Authors:  M Victoria Puig; Earl K Miller
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Aggression, DRD1 polymorphism, and lesion location in penetrating traumatic brain injury.

Authors:  Matteo Pardini; Frank Krueger; Colin A Hodgkinson; Vanessa Raymont; Maren Strenziok; Mario Amore; Eric M Wassermann; David Goldman; Jordan H Grafman
Journal:  CNS Spectr       Date:  2014-03-11       Impact factor: 3.790

4.  Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.

Authors:  Laura Albizu; Terrell Holloway; Javier González-Maeso; Stuart C Sealfon
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

5.  Neural Substrates of Dopamine D2 Receptor Modulated Executive Functions in the Monkey Prefrontal Cortex.

Authors:  M Victoria Puig; Earl K Miller
Journal:  Cereb Cortex       Date:  2014-05-09       Impact factor: 5.357

Review 6.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

7.  Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors.

Authors:  Bing Xue; Li-Min Mao; Dao-Zhong Jin; John Q Wang
Journal:  J Neurosci Res       Date:  2015-07-08       Impact factor: 4.164

8.  Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  Synapse       Date:  2012-12-08       Impact factor: 2.562

9.  Functional 5-HT1a receptor polymorphism selectively modulates error-specific subprocesses of performance monitoring.

Authors:  Christian Beste; Katharina Domschke; Vasil Kolev; Juliana Yordanova; Anna Baffa; Michael Falkenstein; Carsten Konrad
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

10.  Amphetamine elevates phosphorylation of eukaryotic initiation factor 2α (eIF2α) in the rat forebrain via activating dopamine D1 and D2 receptors.

Authors:  Bing Xue; Cole A Fitzgerald; Dao-Zhong Jin; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2016-06-20       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.